Genetic Mutation And Disordered Protein Structure | 12175
ISSN: 2155-952X

Journal of Biotechnology & Biomaterials
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Genetic mutation and disordered protein structure

4th World Congress on Biotechnology

Orkid Coskuner

ScientificTracks Abstracts: J Biotechnol Biomater

DOI: 10.4172/2155-952X.S1.023

Intrinsically disordered proteins lack a stable structure and adopt many various conformations within a short time‐scale. Genetic mutation impacts the structures and free energy landscapes of disordered proteins. The structure and function relationship definition in medicine and biology, which states that the 3‐Dimensional structure of a protein defines its biological function captures native state proteins without serious limitations, however, intrinsically disordered proteins do not possess stable 3‐Dimensional structures and yet they have well defined biological functions. For more than two decades, researchers from diverse fields have been trying to find a direct relationship between the structures and thermodynamic properties of intrinsically disordered proteins. Various tools have been developed without providing a direct relationship between the disordered protein structures and their thermodynamic properties, such as free energy. Most recently, we developed new theoretical strategies that relate genetic mutation directly to disordered protein structures and conformational free energy surfaces. In this talk, we will present these new strategies and their applications on genetic mutation and disordered proteins at the center of neurodegenerative diseases.